CORONA Remedies Limited (CORONA) Share Analysis
NSE · Healthcare · Healthcare
CORONA Remedies Limited (NSE: CORONA) is an Indian listed company in the Healthcare sector and a constituent of NIFTY Microcap 250. As of 14 Nov 2026, the share price was ₹2,330.00, P/E 64.7, ROE 29.5%.
Get the AI verdict on CORONA: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
CORONA chart with trendlines
Is CORONA a buy right now?
Sign in free for the AI verdict with entry zone, targets and stop-loss.
About CORONA Remedies Limited
Stored fundamentals as of 14 Nov 2026 — not a live quote. Signed-in analysis uses same-day data.
CORONA key facts
| Price and valuation | |
|---|---|
| Share price | ₹2,330.00 |
| Market cap | ₹14,248 Cr |
| P/E ratio | 64.7 |
| P/B ratio | 17.65 |
| EPS | ₹33.85 |
| Book value per share | ₹132.00 |
| Dividend yield | 0.43% |
| 52-week range | |
| 52-week high | ₹2,719.30 |
| 52-week low | ₹1,336.60 |
| Face value | ₹10.00 |
| Shareholding pattern | |
| Promoters | 69% |
| FIIs | 4.21% |
| DIIs | 16.44% |
| Public | 10.35% |
Index membership: NIFTY Microcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.